within Pharmacolibrary.Drugs.ATC.J;

model J01DD08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.4,
    Cl             = 0.06166666666666667,
    adminDuration  = 600,
    adminMass      = 0.4,
    adminCount     = 1,
    Vd             = 0.013,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.014166666666666666,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Cefixime is a third-generation oral cephalosporin antibiotic used to treat a variety of bacterial infections including respiratory tract infections, urinary tract infections, otitis media, and gonorrhea. It is approved for clinical use in many countries and is available as oral tablets and suspensions.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects following a single oral dose.</p><h4>References</h4><ol><li>Maria Ajmal, Ammara Zamir, Anees Ur Rehman, Imran Imran, Hamid Saeed, Abdul Majeed, Majid Aziz, Faleh Alqahtani, Muhammad Fawad Rasool,Clinical pharmacokinetics of cefixime: a systematic review.,Xenobiotica; the fate of foreign compounds in biological systems,2023<a href='https://pubmed.ncbi.nlm.nih.gov/37216497/'>https://pubmed.ncbi.nlm.nih.gov/37216497/</a></li><li>Amanda K Sullins, Susan M Abdel-Rahman,Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.,Paediatric drugs,2013<a href='https://pubmed.ncbi.nlm.nih.gov/23529866/'>https://pubmed.ncbi.nlm.nih.gov/23529866/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01DD08;
